Waters Parkerson & Co’s Medtronic MDT Stock Holding History

Waters Parkerson & Co’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$578K	Buy	7,390 +187	+3%	+$15.1K	0.03%	134
2026 Q1	$624K	Hold	7,203	–	–	0.03%	122
2025 Q4	$692K	Hold	7,203	–	–	0.03%	120
2025 Q3	$686K	Hold	7,203	–	–	0.03%	120
2025 Q2	$628K	Hold	7,203	–	–	0.03%	121
2025 Q1	$647K	Buy	7,203 +250	+4%	+$22.4K	0.03%	122
2024 Q4	$555K	Buy	6,953 +1,750	+34%	+$151K	0.03%	129
2024 Q3	$468K	Sell	5,203 -125	-2%	-$10.5K	0.02%	138
2024 Q2	$419K	Buy	+5,328	New	+$437K	0.02%	132
2021 Q1	–	Sell	-3,663	Closed	-$429K	–	176
2020 Q4	$429K	Buy	+3,663	New	+$403K	0.03%	127

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

MGP

M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Waters Parkerson & Co's MDT Position: Q2 2026 in Review

Waters Parkerson & Co increased its Medtronic (MDT) stake by 2.6% in Q2 2026, buying an estimated $15.1K and bringing the position to 7,390 shares worth $578K. The position accounts for 0.03% of the portfolio, ranked #134.

Waters Parkerson & Co first reported a position in MDT in Q4 2020 and has held it in 10 quarters since. The position peaked at $692K in Q4 2025. 1,332 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

Waters Parkerson & Co held 7,390 shares of Medtronic worth $578K as of Q2 2026.
Waters Parkerson & Co bought 187 Medtronic shares in Q2 2026, an estimated $15.1K.
Medtronic made up 0.03% of Waters Parkerson & Co's portfolio in Q2 2026, its #134 holding.
Waters Parkerson & Co first reported a position in Medtronic in Q4 2020 and has held it in 10 quarters since.
Waters Parkerson & Co's Medtronic position peaked at $692K in Q4 2025.
1,332 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Waters Parkerson & Co's 13F filing for Q2 2026, filed 30 Jul 2026.